Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Application of recurrent neural network for online prediction of cell density of recombinant Pichia pastoris producing HBsAg.

Beiroti A, Aghasadeghi MR, Hosseini SN, Norouzian D.

Prep Biochem Biotechnol. 2019;49(4):352-359. doi: 10.1080/10826068.2019.1566153. Epub 2019 Feb 1.

PMID:
30707051
2.

Inherent anti-HIV activity of biocompatible anionic citrate-PEG-citrate dendrimer.

Kandi MR, Mohammadnejad J, Shafiee Ardestani M, Zabihollahi R, Soleymani S, Aghasadeghi MR, Baesi K.

Mol Biol Rep. 2019 Feb;46(1):143-149. doi: 10.1007/s11033-018-4455-6. Epub 2018 Nov 9.

PMID:
30414104
3.

Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria meningitidis Serogroup B: Potent Inducer of the Murine Immune System

Hekmat S, Sadat SM, Aslani MM, Mahdavi M, Bolhassani A, Asgar Halvaee F, Ghahari SMM, Aghasadeghi MR, Siadat SD.

Iran Biomed J. 2019 Jul;23(4):235-45. Epub 2018 Oct 3.

4.

A Novel Molecular Design for a Hybrid Phage-DNA Construct Against DKK1.

Khalili S, Rasaee MJ, Bamdad T, Mard-Soltani M, Asadi Ghalehni M, Jahangiri A, Pouriayevali MH, Aghasadeghi MR, Malaei F.

Mol Biotechnol. 2018 Nov;60(11):833-842. doi: 10.1007/s12033-018-0115-2.

PMID:
30182325
5.

Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015.

Moradi G, Gouya MM, Azimizan Zavareh F, Mohamadi Bolbanabad A, Darvishi S, Aghasadeghi MR, Nabavi M, Alasvand R, Tashakorian M, Nouri B, Rahmani K, Molaei L.

Trop Med Int Health. 2018 Jun;23(6):641-649. doi: 10.1111/tmi.13065. Epub 2018 May 25.

PMID:
29698576
6.

First detection of human hepegivirus-1 (HHpgV-1) in Iranian patients with hemophilia.

Bijvand Y, Aghasadeghi MR, Sakhaee F, Pakzad P, Vaziri F, Saraji AA, Jamnani FR, Siadat SD, Fateh A.

Sci Rep. 2018 Mar 22;8(1):5036. doi: 10.1038/s41598-018-23490-4.

7.

No genetic association between A118G polymorphism of μ-opioid receptor gene and schizophrenia and bipolar disorders.

Yazdani S, Salimi V, Eshraghian MR, Shayestehpour M, Pourtalebi-Firoozabadi A, Romani B, Shadab A, Aghasadeghi MR, Yavarian J.

Indian J Psychiatry. 2017 Oct-Dec;59(4):483-486. doi: 10.4103/psychiatry.IndianJPsychiatry_53_17.

8.

Evaluation of autophagy induction on HEV 239 vaccine immune response in a mouse model.

Khateri M, Abdoli A, Motevalli F, Fotouhi F, Bolhassani A, Arashkia A, Jazaeri EO, Shahbazi S, Mehrbod P, Naziri H, Aghasadeghi MR.

IUBMB Life. 2018 Mar;70(3):207-214. doi: 10.1002/iub.1719. Epub 2018 Jan 25.

9.

Design, Synthesis, Molecular Modeling, In Silico ADME Studies and Anti-HIV-1 Assay of New Diazocoumarin Derivatives.

Alimi Livani Z, Safakish M, Hajimahdi Z, Soleymani S, Zabihollahi R, Aghasadeghi MR, Alipour E, Zarghi A.

Iran J Pharm Res. 2018;17(Suppl2):65-77.

10.

Comparison of antiretroviral drug resistance among treatment-naive and treated HIV-infected individuals in Shiraz, Iran.

Davarpanah MA, Motazedian N, Joulaei H, Aghasadeghi MR, Faramarzi H, Aghah E.

Arch Virol. 2018 Jan;163(1):99-104. doi: 10.1007/s00705-017-3549-0. Epub 2017 Oct 6.

PMID:
28986714
11.

Prevalence of HIV, HBV, and HCV and Related Risk Factors amongst Male Homeless People in Lorestan Province, the West of Iran.

Doosti-Irani A, Mokhaeri H, Chegini Sharafi A, Aghasadeghi MR, Hajimiragha M, Saki M, Kayedi MH, Mostafavi E.

J Res Health Sci. 2017 Mar 11;17(1):e00373.

12.

Conjugated anionic PEG-citrate G2 dendrimer with multi-epitopic HIV-1 vaccine candidate enhance the cellular immune responses in mice.

Abdoli A, Radmehr N, Bolhassani A, Eidi A, Mehrbod P, Motevalli F, Kianmehr Z, Chiani M, Mahdavi M, Yazdani S, Ardestani MS, Kandi MR, Aghasadeghi MR.

Artif Cells Nanomed Biotechnol. 2017 Dec;45(8):1762-1768. doi: 10.1080/21691401.2017.1290642. Epub 2017 Feb 20.

PMID:
28278580
13.

Evaluation of Truncated HCV-NS3 Protein for Potential Applications in Immunization and Diagnosis.

Javadi F, Rahimi P, Modarressi MH, Bolhassani A, Ardestani MS, Sadat SM, Aghasadeghi MR.

Clin Lab. 2016 Jul 1;62(7):1271-1278. doi: 10.7754/Clin.Lab.2015.151118.

PMID:
28164628
14.

Expression of HCV Alternative Reading Frame Protein (Core+1/F) in Baculovirus Expression System and its Evaluation for Assessment of Specific Anti-core+1 Antibody in Iranian HCV Infected Patients.

Rahimi P, Vahabpour R, Fard FS, Motevalli F, Chahouki FF, Aghasadeghi MR, Bolhassani A, Sadat SM, Mostafavi E, Mohajel N, Jahanian-Najafabadi A, Amiran MR.

Clin Lab. 2016 Oct 1;62(10):1919-1926. doi: 10.7754/Clin.Lab.2016.160205.

PMID:
28164534
15.

Role of IL28-B Polymorphism (rs12979860) on Sustained Virological Response to Pegylated Interferon/Ribavirin in Iranian Patients With Chronic Hepatitis C.

Daneshvar M, Nikbin M, Talebi S, Javadi F, Aghasadeghi MR, Mahmazi S, Sadat SM.

Iran Red Crescent Med J. 2016 Jul 17;18(9):e28566. doi: 10.5812/ircmj.28566. eCollection 2016 Sep.

16.

Design, Construction and Evaluation of 1a/JFH1 HCV Chimera by Replacing the Intergenotypic Variable Region.

Ghasemi F, Ghayour-Mobarhan M, Pasdar A, Pourianfar H, Reza Aghasadeghi M, Gouklani H, Meshkat Z.

Hepat Mon. 2016 Aug 7;16(10):e38261. eCollection 2016 Oct.

17.

Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity.

Assadi A, Najafabadi VS, Shandiz SA, Boroujeni AS, Ashrafi S, Vaziri AZ, Ghoreishi SM, Aghasadeghi MR, Ebrahimi SE, Pirali-Hamedani M, Ardestani MS.

Onco Targets Ther. 2016 Sep 7;9:5531-43. doi: 10.2147/OTT.S103487. eCollection 2016.

18.

Smart bomb AS1411 aptamer-functionalized/PAMAM dendrimer nanocarriers for targeted drug delivery in the treatment of gastric cancer.

Barzegar Behrooz A, Nabavizadeh F, Adiban J, Shafiee Ardestani M, Vahabpour R, Aghasadeghi MR, Sohanaki H.

Clin Exp Pharmacol Physiol. 2017 Jan;44(1):41-51. doi: 10.1111/1440-1681.12670.

PMID:
27626786
19.

Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.

Aghasadeghi MR, Velayati AA, Mamishi S, Nabavi M, Aghakhani A, Bidari-Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifazl M, Azimian-Zavareh F, Motevalli F, Soleymani S, Ramezani A.

Arch Virol. 2016 Dec;161(12):3405-3411. Epub 2016 Sep 9.

PMID:
27613286
20.

Venom Components of Iranian Scorpion Hemiscorpius lepturus Inhibit the Growth and Replication of Human Immunodeficiency Virus 1 (HIV-1).

Zabihollahi R, Pooshang Bagheri K, Keshavarz Z, Motevalli F, Bahramali G, Siadat SD, Momen SB, Shahbazzadeh D, Aghasadeghi MR.

Iran Biomed J. 2016 Nov;20(5):259-65. Epub 2016 Sep 4.

21.

HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.

Romani B, Kamali Jamil R, Hamidi-Fard M, Rahimi P, Momen SB, Aghasadeghi MR, Allahbakhshi E.

Sci Rep. 2016 Aug 23;6:31924. doi: 10.1038/srep31924.

22.

Prevalence of Merkel Cell Polyomavirus in Tehran: An Age-Specific Serological Study.

Vahabpour R, Aghasadeghi MR, Salehi-Vaziri M, Mohajel N, Keyvani H, Nasimi M, Esghaei M, Monavari SH.

Iran Red Crescent Med J. 2016 Feb 14;18(5):e26097. doi: 10.5812/ircmj.26097. eCollection 2016 May.

23.

Recombinant C-terminal 311 amino acids of HapS adhesin as a vaccine candidate for nontypeable Haemophilus influenzae: A study on immunoreactivity in Balb/C mouse.

Tabatabaee Bafroee AS, Siadat SD, Mousavi SF, Aghasadeghi MR, Khorsand H, Nejati M, Sadat SM, Mahdavi M.

Microb Pathog. 2016 Sep;98:106-11. doi: 10.1016/j.micpath.2016.06.033. Epub 2016 Jul 1.

PMID:
27377430
24.

Construction and Immunogenicity Analysis of Hepatitis C Virus (HCV) Truncated Non-Structural Protein 3 (NS3) Plasmid Vaccine.

Pouriayevali MH, Bamdad T, Aghasadeghi MR, Sadat SM, Sabahi F.

Jundishapur J Microbiol. 2016 Mar 19;9(3):e33909. doi: 10.5812/jjm.33909. eCollection 2016 Mar.

25.

Impact of TGF-β1 Gene Polymorphism (rs1800469) on Treatment Response to Pegylated Interferon/Ribavirin in Iranian Patients with Hepatitis C.

Larijani MS, Rad LN, Nikbin M, Bahiraei N, Javadi F, Daneshvar M, Aghasadeghi MR, Rahimi P, Siadat SD, Zabihollahi R, Sadat SM.

Clin Lab. 2016;62(4):609-14.

PMID:
27215079
26.

Correlation Study Between IL-28B Gene Polymorphism (rs8099917SNP) and Sustained Virological Response in Iranian Patients with Chronic Hepatitis C.

Larijani MS, Sadat SM, Nikbin M, Talebi SS, Javadi F, Mohajel N, Bolhassani A, Daneshvar M, Aghasadeghi MR, Pouriayevali MH, Mapar M.

Clin Lab. 2016;62(3):417-23.

PMID:
27156332
27.

Construction and Production of Foxp3-Fc (IgG) DNA Vaccine/Fusion Protein.

Mousavi Niri N, Memarnejadian A, Hadjati J, Aghasadeghi MR, Shokri M, Pilehvar-Soltanahmadi Y, Akbarzadeh A, Zarghami N.

Avicenna J Med Biotechnol. 2016 Apr-Jun;8(2):57-64.

28.

Toward the development of a single-round infection assay based on EGFP reporting for anti-HIV-1 drug discovery.

Soezi M, Memarnejadian A, Aminzadeh S, Zabihollahi R, Sadat SM, Amini S, Hekmat S, Aghasadeghi MR.

Rep Biochem Mol Biol. 2015 Oct;4(1):1-9.

29.

Impact of null genotypes of GSTT1 and GSTM1 with uterine leiomyoma risk in Iranian population.

Mostafavi SS, Ebrahimi A, Sadat SM, Davari Tanha F, Aghasadeghi MR, Bahramali G, Abbasi Ranjbar P, Sadeghifard V, Javadi F.

J Obstet Gynaecol Res. 2016 Apr;42(4):434-9. doi: 10.1111/jog.12924. Epub 2016 Jan 20.

PMID:
26785830
30.

Design and expression of fusion protein consists of HBsAg and Polyepitope of HCV as an HCV potential vaccine.

Gholizadeh M, Khanahmad H, Memarnejadian A, Aghasadeghi MR, Roohvand F, Sadat SM, Cohan RA, Nazemi A, Motevalli F, Asgary V, Arezumand R.

Adv Biomed Res. 2015 Oct 29;4:243. doi: 10.4103/2277-9175.168610. eCollection 2015.

31.

HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages.

Romani B, Baygloo NS, Hamidi-Fard M, Aghasadeghi MR, Allahbakhshi E.

J Biol Chem. 2016 Feb 5;291(6):2696-711. doi: 10.1074/jbc.M115.689018. Epub 2015 Dec 17.

32.

Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses.

Bolhassani A, Kardani K, Vahabpour R, Habibzadeh N, Aghasadeghi MR, Sadat SM, Agi E.

Immunol Lett. 2015 Dec;168(2):366-73. doi: 10.1016/j.imlet.2015.10.012. Epub 2015 Oct 27.

PMID:
26518142
33.

Correction: Neutralizing Antibody Response after Intramuscular Purified Vero Cell Rabies Vaccination (PVRV) in Iranian Patients with Specific Medical Conditions.

Rahimi P, Vahabpour R, Aghasadeghi MR, Sadat SM, Howaizi N, Mostafavi E, Eslamifar A, Fallahian V.

PLoS One. 2015 Oct 30;10(10):e0142244. doi: 10.1371/journal.pone.0142244. eCollection 2015. No abstract available.

34.

Expression and Purification of the Uropathogenic Escherichia coli PapG Protein and its Surface Absorption on Lactobacillus reuteri: Implications for Surface Display System Vaccines.

Ashrafi F, Fallah Mehrabadi J, Siadat SD, Aghasadeghi MR.

Jundishapur J Microbiol. 2015 Sep 8;8(9):e25595. doi: 10.5812/jjm.25595. eCollection 2015 Sep.

35.

Neutralizing Antibody Response after Intramuscular Purified Vero Cell Rabies Vaccination (PVRV) in Iranian Patients with Specific Medical Conditions.

Rahimi P, Vahabpour R, Aghasadeghi MR, Sadat SM, Howaizi N, Mostafavi E, Eslamifar A, Fallahian V.

PLoS One. 2015 Oct 6;10(10):e0139171. doi: 10.1371/journal.pone.0139171. eCollection 2015. Erratum in: PLoS One. 2015;10(10):e0142244.

36.

Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.

Velashjerdi Farahani S, Reza Aghasadeghi M, Memarnejadian A, Faezi S, Shahosseini Z, Mahdavi M.

Pathog Glob Health. 2016 Mar;110(2):39-47. doi: 10.1179/2047773215Y.0000000035. Epub 2016 Apr 13.

37.

Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.

Aghakhani A, Mohraz M, Aghasadeghi MR, Banifazl M, Vahabpour R, Karami A, Foroughi M, Ramezani A.

Int J STD AIDS. 2016 Oct;27(11):967-72. doi: 10.1177/0956462415602419. Epub 2015 Sep 18.

PMID:
26384943
38.

HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.

Romani B, Shaykh Baygloo N, Aghasadeghi MR, Allahbakhshi E.

J Biol Chem. 2015 Jul 10;290(28):17380-9. doi: 10.1074/jbc.M115.641522. Epub 2015 Jun 1.

39.

MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7.

Saleh T, Bolhassani A, Shojaosadati SA, Aghasadeghi MR.

Vaccine. 2015 Jun 22;33(28):3164-70. doi: 10.1016/j.vaccine.2015.05.015. Epub 2015 May 19.

PMID:
26001433
40.

Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.

Memarnejadian A, Menbari S, Mansouri SA, Sadeghi L, Vahabpour R, Aghasadeghi MR, Mostafavi E, Abdi M.

PLoS One. 2015 May 11;10(5):e0126955. doi: 10.1371/journal.pone.0126955. eCollection 2015.

41.

Nanosilver based anionic linear globular dendrimer with a special significant antiretroviral activity.

Ardestani MS, Fordoei AS, Abdoli A, Ahangari Cohan R, Bahramali G, Sadat SM, Siadat SD, Moloudian H, Nassiri Koopaei N, Bolhasani A, Rahimi P, Hekmat S, Davari M, Aghasadeghi MR.

J Mater Sci Mater Med. 2015 May;26(5):179. doi: 10.1007/s10856-015-5510-7. Epub 2015 Apr 17.

PMID:
25893388
42.

No evidence for occult HBV infection in hepatitis B vaccine non-responders.

Aghasadeghi MR, Banifazl M, Aghakhani A, Eslamifar A, Vahabpour R, Ramezani A.

Iran J Microbiol. 2014 Oct;6(5):350-3.

43.

High resolution melting curve assay for detecting rs12979860 IL28B polymorphisms involved in response of Iranian patients to chronic hepatitis C treatment.

Fateh A, Aghasadeghi MR, Keyvani H, Mollaie HR, Yari S, Hadizade Tasbiti AR, Ghazanfari M, Monavari SH.

Asian Pac J Cancer Prev. 2015;16(5):1873-80.

44.

Isolated anti-hbc and occult HBV infection in dialysis patients.

Ramezani A, Aghasadeghi MR, Ahmadi F, Razeghi E, Eslamifar A, Banifazl M, Sofian M, Bahramali G, Hekmat S, Aghakhani A.

Nephrourol Mon. 2014 Nov 30;7(1):e22674. doi: 10.5812/numonthly.22674. eCollection 2015 Jan.

45.

Induction of Strong and Specific Humoral and T-helper 1 Cellular Responses by HBsAg Entrapped in the Methanobrevibacter smithii Archaeosomes.

Aghasadeghi MR, Delbaz SA, Sadat SM, Siadat SD, Ardestani MS, Rahimi P, Bolhassani A, Roudsari RV, Bahramali G, Motevalli F, Davari M, Vakily H, Salmani AS, Nobari MB.

Avicenna J Med Biotechnol. 2014 Oct;6(4):238-45.

46.

Vulnerability of homeless people in Tehran, Iran, to HIV, tuberculosis and viral hepatitis.

Amiri FB, Gouya MM, Saifi M, Rohani M, Tabarsi P, Sedaghat A, Fahimfar N, Memarnejadian A, Aghasadeghi MR, Haghdoost AA, Jahanbakhsh F, Nasehi M, Mostafavi E.

PLoS One. 2014 Jun 4;9(6):e98742. doi: 10.1371/journal.pone.0098742. eCollection 2014.

47.

Clustered epitopes within a new poly-epitopic HIV-1 DNA vaccine shows immunogenicity in BALB/c mice.

Jafarpour N, Memarnejadian A, Aghasadeghi MR, Kohram F, Aghababa H, Khoramabadi N, Mahdavi M.

Mol Biol Rep. 2014 Aug;41(8):5207-14. doi: 10.1007/s11033-014-3388-y. Epub 2014 May 20.

PMID:
24842263
48.

Induction of IFN-γ cytokine response against hepatitis B surface antigen using melittin.

Dezfuli HT, Shahbazzadeh D, Eidi A, Bagheri KP, Pakravan N, Amini S, Aghasadeghi MR, Mahdavi M.

Gastroenterol Hepatol Bed Bench. 2014 Spring;7(2):108-17.

49.

Genotypic and phenotypic comparison of enteroaggregative Escherichia coli isolates from HIV-positive and non-HIV diarrheal samples.

Jafari A, Shafaei E, Oloomi M, Aghasadeghi MR, Bouzari S.

Curr HIV Res. 2013 Dec;11(8):635-41.

PMID:
24517190
50.

Immunization of Mice by BCG Formulated HCV Core Protein Elicited Higher Th1-Oriented Responses Compared to Pluronic-F127 Copolymer.

Yazdanian M, Memarnejadian A, Mahdavi M, Sadat SM, Motevali F, Vahabpour R, Khanahmad H, Siadat SD, Aghasadeghi MR, Roohvand F.

Hepat Mon. 2013 Oct 23;13(10):e14178. doi: 10.5812/hepatmon.14178. eCollection 2013.

Supplemental Content

Loading ...
Support Center